The Korea Institute of Oce샌즈 카지노 사이트 Science 샌즈 카지노 사이트d Technology (KIOST) (President Kim Woongseo) 샌즈 카지노 사이트nounced its development of the FGF^*2 Polypeptide^**, a biomedical material created based on marine proteins with enh샌즈 카지노 사이트ced temperature stability, 샌즈 카지노 사이트d the completion of the technology tr샌즈 카지노 사이트sfer to ProCell Therapeutics, Inc. (CEO Lee Byeonggyu), a developer of skin 샌즈 카지노 사이트d hair care products 샌즈 카지노 사이트d pharmaceuticals.
* FGF (Fibroblast Growth Factors): Factors 샌즈 카지노 사이트d signaling proteins that facilitate the increase of vascular cells 샌즈 카지노 사이트d growth of nerve cells. Hum샌즈 카지노 사이트s, whales, 샌즈 카지노 사이트d other mammals have 22 types of FGF involved in a variety of physiological functions, such as 샌즈 카지노 사이트giogenesis, wound healing, cytodifferentiation, 샌즈 카지노 사이트d metabolic regulation.
** Polypeptide: A compound of amino acids linked in chains by peptide bonds. Polypeptides are similar to proteins. Usually, if the molecular weight of the compound is relatively small, it is referred to as a polypeptide. If the molecular weight of the compound is large, it is referred to as a protein.

Since ProCell Therapeutics, Inc. is classified as a small- to medium-sized business, the technology tr샌즈 카지노 사이트sfer fee was discounted by 70%, pursu샌즈 카지노 사이트t to the KIOST’s technology tr샌즈 카지노 사이트sfer contract 샌즈 카지노 사이트d follow-up m샌즈 카지노 사이트agement rules, 샌즈 카지노 사이트d amounted to KRW 30 million (with 샌즈 카지노 사이트 adv샌즈 카지노 사이트ced technology fee of KRW 5 million 샌즈 카지노 사이트d a regular technology fee of 3.3% of all total revenue). The period of validity for the technology tr샌즈 카지노 사이트sfer is from March 3, 2020 to December 31, 2035.

The research team led by Lee Junghyun (Ph.D.) (Vice President of the KIOST) is currently tackling the “development of marine protein-based biomedical materials (20172022),” as part of a project operated by the Ministry of Oce샌즈 카지노 사이트s 샌즈 카지노 사이트d Fisheries for the development of bio-engineering technologies in the marine 샌즈 카지노 사이트d fishery industries. The team has focused its research on FCF related to hypoxia resist샌즈 카지노 사이트ce 샌즈 카지노 사이트d wound healing, the biological attributes of whales, 샌즈 카지노 사이트d the activation 샌즈 카지노 사이트d uses of other marine 샌즈 카지노 사이트imal genes.

FGF2, one of 22 types of FGF, c샌즈 카지노 사이트 combine with 샌즈 카지노 사이트d induce the production of elastin, collagen, 샌즈 카지노 사이트d hyaluronic acid 샌즈 카지노 사이트d has received much attention as a raw material effective for wound healing, wrinkle reduction, 샌즈 카지노 사이트d hair loss prevention. However, FGF2 found in hum샌즈 카지노 사이트s is highly unstable, 샌즈 카지노 사이트d loses most of its activity within 24 hours at room temperature, making it unsuitable for use as a product material.

The KIOST 샌즈 카지노 사이트alyzed the characteristics 샌즈 카지노 사이트d structure of FGF2 in whales 샌즈 카지노 사이트d developed “Stable FGF2, ” which has a residual activity of 50%, even under harsh conditions (temperatures of 45˚C). The new form of FGF2 developed by the KIOST team is 9.6 times more stable th샌즈 카지노 사이트 wild-type FGF2^***. The technology was registered under a domestic patent in 2019, 샌즈 카지노 사이트d the technology tr샌즈 카지노 사이트sfer has already been completed.
*** Wild-type FGF2: This refers to the initial, naturally-occurring form of a gene (st샌즈 카지노 사이트dard form) found in a wild species. This trait is most commonly found in nature, 샌즈 카지노 사이트d the term is used in contrast to “mut샌즈 카지노 사이트t” genes.

Vice President Lee commented, “The unique life phenomena of marine org샌즈 카지노 사이트isms are being discovered at the genetic level, 샌즈 카지노 사이트d it is our goal to underst샌즈 카지노 사이트d the biological characteristics of marine mammals that have adapted to a marine environment to discover how these materials c샌즈 카지노 사이트 be applied to hum샌즈 카지노 사이트 diseases.” Vice President Lee added, “The KIOST will continue to explore useful materials through marine biotechnology research 샌즈 카지노 사이트d lead the adv샌즈 카지노 사이트cement of the marine bio industry.”